David Patrick Nixon
Chairman and CEODavid brings 23 years of healthcare experience and a record of entrepreneurial leadership to his role as CEO of InformedDNA. Since joining InformedDNA in 2007, David has led the company’s transformation from the premier national genetic counseling provider network to becoming the first mover in the rapidly growing field of genetic testing utilization management. InformedDNA is now the leading genetic benefits management organization; working with national and regional health plans as well as hospitals and health systems throughout the US to ensure patients have convenient access to genetic services and providers are able to work with genetic specialists for genetic testing decision support.
Dr. Bard Geesaman, MD, PhD
DirectorDr. Bard Geesaman joined InformedDNA's board of directors following an investment in the company by MPM Capital Partners' SunStates Fund LP. Bard began working with MPM in 2001 as part of the management team for the portfolio company Elixir Pharmaceuticals. In 2006 he became a venture partner at MPM and co-founded Solasia, a specialty pharmaceutical company in Asia developing oncology products. Prior to working at MPM, Bard was a general partner at F2 Ventures, a U.K. based investment firm where he managed private investments. Bard received his Ph.D. in systems biology from MIT, his M.D. from Harvard Medical School, and his bachelor’s degree in neurobiology from the University of California, Berkeley. He is board certified in internal medicine and completed his residency at Massachusetts General Hospital.
Jannifer Drake Harper, MD
DirectorDr. Jannifer Harper is vice president and chief clinical officer, Anthem National Accounts, Anthem Inc. In this role, she is responsible for developing and delivering ANA clinical strategy for large national customers as well as leading ANA clinical operations and clinical product implementation functions for over seven million lives. Prior to Joining Anthem, Dr. Harper served as Florida Blue’s vice president and chief medical officer where she was responsible for the development of the overarching clinical strategy for Florida Blue and leading clinical activities including care management, health promotions and wellness, pharmacy, quality, and clinical retail health initiatives. Dr. Harper has also held leadership roles as regional vice president, national medical director for Anthem/WellPoint; chief of medicine, Kaiser Permanente; vice president and regional medical director, CIGNA; medical director, the Medical Group of Ohio and Ohio Health Group; vice president and associate chief of medical officer of University Hospitals Case Medical Center of Cleveland; and, clinical assistant professor of medicine at Case Western Reserve University School of Medicine, where she received her medical degree. Dr. Harper is a member of the American Association of Physician Leadership, the American College of Physicians, the CWRU School of Medicine Alumni Board, and the Georgia Chapter of the American Lung Association Board of Directors. She is board certified in internal medicine and holds a Certified Physician Executive (CPE) designation from the Certifying Commission in Medical Management.
Stephen M. Mengert
DirectorStephen Mengert has been a senior financial executive in healthcare and finance for over 20 years, including 13 years as the chief financial officer of a public company. Stephen served as senior vice president of finance and chief financial officer of Medsolutions from 2006 to 2011. Before joining MedSolutions, he was the CFO for Matria Healthcare, a publicly traded disease management services company. Stephen earned a bachelor's and master’s degree in business administration with a specialty in finance from Georgia State University. He is a member of the Financial Executives Institute. In 2010, he was Tennessee’s finalist for CFO of the year.
Bruce Nash, MD, MBA
DirectorDr. Bruce Nash is the Chief Physician Executive and Senior Vice President of Health and Medical Management for Blue Cross Blue Shield of Massachusetts.
Dr. Nash has held executive leadership positions for both health plans and hospitals during his career. Prior roles include serving as the Chief Medical Officer of Capital District Physicians’ Health Plan (CDPHP) in Albany, NY, the President of North Adams Regional Hospital, the Vice President of Clinical Affairs, Kaiser Permanente - Northeast, and an extensive tenure with Community Health Plan in Latham, New York.
Dr. Nash is a board certified family physician who practiced for more than 20 years in southern Vermont. He earned a master’s of business administration in health sector management from the Fuqua School of Business of Duke University, a medical degree from Albany Medical College, and a bachelor’s of science degree from Rensselaer Polytechnic Institute. He completed his residency in family practice at Duke University.
He currently serves on the Boards of Directors of the Network for Excellence in Health Innovation (NEHI), the Blue Cross Blue Shield Foundation, the Greater Boston Food Bank, Informed DNA, the Board of Strategic Advisors of the Excel Venture Management Fund, and the Strategic Advisory Council of Change Healthcare.
John N. Nunnelly
DirectorJohn Nunnelly is a retired group president from McKesson Corporation where he was responsible for a broad range of business units in the healthcare information technology industry. John is currently a member of the board of directors for National Research Corporation, a leading provider of performance measurement services for healthcare payer and provider organizations. He also serves as a director for Illuminate Health LLC, an NRCI affiliate. In addition, John is an adjunct professor in the College of Nursing at the University of Massachusetts. He serves on numerous community boards. John graduated from the United States Merchant Marine Academy, Kings Point, and earned his master’s degree in business administration from the University of Massachusetts, Isenberg School of Management.
Rebecca Sutphen, MD, FACMG
Co-Founder and Chief Medical OfficerDr. Rebecca Sutphen has broad clinical and molecular genetics expertise in conditions affecting both adults and children. She is among the few individuals certified by the American Board of Medical Genetics in clinical genetics, molecular genetics and cytogenetics. Rebecca previously served as director of Clinical Genetics for Moffitt Cancer Center & Research Institute. She is also an experienced researcher in genomics & proteomics and has been funded by the American Cancer Society, the Department of Defense and the National Institutes of Health. Rebecca has received numerous awards and honors, including being named to "Florida's Super Doctors," "America's Top Doctors for Cancer," and "Best Doctors in America," as well as the National Comprehensive Cancer Network Guidelines Panel, which sets the standard-of-care for genetics and familial cancer screening.